A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Asian Patients With Advanced Cancer

NCT03808870 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Neoplasm

Interventions

DRUG: NBM-BMX softgel capsules

Sponsor

NatureWise Biotech & Medicals Corporation